- Home
- STEW vs TLRY Comparison
STEW vs TLRY Comparison
Compare STEW & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STEW | TLRY |
|---|---|---|
| Founded | 1972 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | STEW | TLRY |
|---|---|---|
| Price | $18.35 | $11.22 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $150.00 |
| AVG Volume (30 Days) | 84.5K | ★ 9.5M |
| Earning Date | 01-01-0001 | 01-09-2026 |
| Dividend Yield | ★ 3.71% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.44 | N/A |
| Revenue | N/A | ★ $830,766,000.00 |
| Revenue This Year | N/A | $7.28 |
| Revenue Next Year | N/A | $4.51 |
| P/E Ratio | $10.34 | ★ N/A |
| Revenue Growth | N/A | ★ 2.31 |
| 52 Week Low | $11.97 | $3.51 |
| 52 Week High | $14.94 | $23.20 |
Technical Indicators
Market Signals| Indicator | STEW | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 61.01 | 83.13 |
| Support Level | $17.76 | $7.10 |
| Resistance Level | $18.20 | $8.64 |
| Average True Range (ATR) | 0.19 | 0.73 |
| MACD | 0.02 | 0.76 |
| Stochastic Oscillator | 83.08 | 87.73 |
Price Performance
Historical ComparisonAbout STEW SRH Total Return Fund Inc.
SRH Total Return Fund, Inc. is a non-diversified closed-end management investment company. The company's investment objective is to seek total returns. Its fund utilizes a bottom-up, value-driven investment process to identify securities of good quality businesses trading below estimated intrinsic value. The Funds are available as an actively-managed closed-end fund, an actively managed ETF and a passively-managed ETF.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.